Quarterly report · Q2
4320.TEDINET S100TDO6
Period2023-10-01 → 2024-03-31
Filed2024-05-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥8.1bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥13.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥7.3bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥741m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥840m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥744m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥838m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥744m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥861m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥372m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥688m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥495m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥405m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥536m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥12.9bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥11.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥11.2bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.1bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥4.7bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥6.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.3bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥3.4bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.1bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥3.4bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.0bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥451m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥796m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥289m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥353m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥862m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥254m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥1.0bn | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥755m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥194m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥24.77 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.68 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥45.91 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥32.99 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥26.5 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 49.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.1% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 20
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | −¥25m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥7.9bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥798m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥202m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥202m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | −¥32m |
| —segment total | revenue | 2023-10-01 → 2024-03-31 | ¥8.1bn |
| —segment total | revenue external | 2023-10-01 → 2024-03-31 | ¥8.1bn |
| —segment total | segment profit | 2023-10-01 → 2024-03-31 | ¥766m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | −¥26m |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥7.1bn |
| jpcrp040300-q2r_E05233-000Heathcare Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥873m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥240m |
| jpcrp040300-q2r_E05233-000Marketing Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | −¥8m |
| —segment total | revenue | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | revenue external | 2022-10-01 → 2023-03-31 | ¥7.3bn |
| —segment total | segment profit | 2022-10-01 → 2023-03-31 | ¥865m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 482
| Item | Context | Value | Unit |
|---|---|---|---|
| Amortization of goodwill ope cf | Prior1YTDDuration | 23183000 | JPY |
| Amortization of goodwill ope cf | CurrentYTDDuration | 21787000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | Prior1YTDDuration | -41921000 | JPY |
| Increase decrease in allowance for doubtful accounts ope cf | CurrentYTDDuration | 1581000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -1409000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -1064000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 3642000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 5165000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -1149674000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -1298617000 | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | Prior1YTDDuration | 46119000 | JPY |
| Decrease increase in claims provable in bankruptcy claims provable in rehabilitation ope cf | CurrentYTDDuration | － | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | 102258000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -50353000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -71196000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | 305029000 | JPY |
| Increase decrease in accounts payable other ope cf | Prior1YTDDuration | -49466000 | JPY |
| Increase decrease in accounts payable other ope cf | CurrentYTDDuration | -119565000 | JPY |
| Other net ope cf | Prior1YTDDuration | 134334000 | JPY |
| Other net ope cf | CurrentYTDDuration | -98118000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 29597000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -280186000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 1404000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 1058000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -3642000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -5165000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -368417000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -252945000 | JPY |
| Income taxes refund ope cf | Prior1YTDDuration | 52163000 | JPY |
| Income taxes refund ope cf | CurrentYTDDuration | 85988000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | -288894000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | -451249000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -38149000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -25874000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -185288000 | JPY |
| Purchase of intangible assets inv cf | CurrentYTDDuration | -320170000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -700000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -4600000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 9483000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | 9492000 | JPY |
| Proceeds from share of profits on investments in partnership | Prior1YTDDuration | 1572000 | JPY |
| Proceeds from share of profits on investments in partnership | CurrentYTDDuration | 93000 | JPY |
| Other net inv cf | Prior1YTDDuration | -41011000 | JPY |
| Other net inv cf | CurrentYTDDuration | -12295000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -254093000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -353354000 | JPY |
| Increase decrease in short term loans payable fin cf | Prior1YTDDuration | 390000000 | JPY |
| Increase decrease in short term loans payable fin cf | CurrentYTDDuration | -200000000 | JPY |
| Proceeds from long term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Proceeds from long term loans payable fin cf | CurrentYTDDuration | 1800000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |